ALEVIN THERAPEUTICS LIMITED

Company number 13971892 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£365,525

Balance sheet as at 2025-03-31

View full accounts →

What it does

72190

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2022-03-11
Employees
0 (2025 accounts)
Registered office
Hauxton House, Mill Sci Tech Park Mill Lane, Hauxton, Cambridge, England, CB22 5HX
Postcode
CB22 5HX
Capital
2 GBP
Accounts category
Micro

Accounts

Last made up to
2025-03-31
Next due by
2026-12-31
Financial year end
31 March

Confirmation statement

Last statement dated
2026-03-10
Next due by
2027-03-24
View filing history →

Nature of business (SIC)

  • 72190 Other research and experimental development on natural sciences and engineering

Officers 3 current

Sunil Rajen SHAH Director
Appointed 2022-04-20
Appointed 2022-04-20
Thomas MCINALLY Director
Appointed 2022-03-11

View all officers and resignations →

Group structure

Controlled by BLOKKX LTD. — since 2022-07-22

Controlled by UNIVERSITY OF NOTTINGHAM (THE) — since 2022-07-22

From persons-with-significant-control filings on the public register.

Contact details

Website
alevintherapeutics.com

Our mission is to develop safe and effective medicines for patients with life-threatening diseases through targeted integrin therapies

Among its peers

Top 25%

by shareholders' funds, of 213 similar companies in CB

Trading since 2022.

Competitors Cambridge

This company ranks 42 among other research and experimental development on natural sciences and engineering in Cambridge.

Full league table →